Activated human lymphocytes and aggressive non-hodgldn’s lymphomas express a homologue of the rat metastasis-associated variant of CD44

Journal of Experimental Medicine

Volumn 177, Issue 4, 1993, Pages 897-904

  Koopman, Gerrit ^a   Heider, Karl Hein ^b   Horst, Eveliene ^a   Adolf, Günther R ^c   Van Den Berg, Frank ^a   Ponta, Helmut ^b   Herrlich, Peter ^b   Pals, Steven T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^c Bender and Co GmbH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; HYBRID PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; EXON; HUMAN; HUMAN CELL; IMMUNOREGULATION; LIGAND BINDING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; LYMPHOID CELL; METASTASIS; NONHODGKIN LYMPHOMA; PANCREAS CARCINOMA; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SARCOMA; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMAL; ANTIBODIES; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; DNA; HUMAN; LYMPHOCYTE ACTIVATION; LYMPHOMA, NON-HODGKIN; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; RATS; RECEPTORS, LYMPHOCYTE HOMING; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0027523091     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.177.4.897     Document Type: Article

References (34)

1. Nicolson, G.L. 1987. Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res. 47:1473.
2. Hart, I.R., N.T. Goode, and R.E. Wilson. 1989. Molecular aspects of the metastatic cascade. Biochim. Biophys. Acta. 989:65.
3. Pals, S.T., E. Horst, G.J. Ossekoppele, C.G. Figdor, R.J. Scheper, and C.J.L.M. Meijer. 1989. Expression of lymphocyte homing receptor (CD44) as a mechanism of dissemination in non-Hodgkiris lymphoma. Blood. 73:885.
4. Horst, E., C.J.L.M. Meijer, T. Radaszkiewicz, G.J. Ossekoppele, J.H.J.M. van Krieken, and S.T. Pals. 1990. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CDlla/CD18), and ICAM-1 (CD54). Leukemia (Baltimore). 4:595.
5. Jalkanen, S., H. Joensuu, and P. Klemi. 1990. Prognostic value of lymphocyte homing receptor and S value in non-Hodgkiris lymphoma. Blood. 75:1549.
6. Sy, M.S., Y.I. Guo, and I. Stamenkovic. 1991. Distinct effects of two CD44 isoforms on tumor growth in vivo .J. Exp Med. 174:859.
7. Birch, M., S. Mitchell, and I. Hart. 1991. Isolation and characterization of human melanoma variants expressing high and low levels of CD44. Cancer Res. 51:6660.
8. Gunthert, U., M. Hofmann, W. Rudy, S. Reber, M. Zoller, I. HauBmann, S. Matzku, A. Wenzel, H. POnta, and P. Herrlich. 1991. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 65:13.
9. Hofmann, M., W. Rudy, M. Zoller, C. Tolg, H. Ponta, P. Herrlich, and U. Gunthert. 1991. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res. 51:5292.
10. Reber, S., S. Matzku, U. Gunthert, H. Ponta, and M. Zoller. 1990. Retardation of metastatic growth after immunization with metastasis-specific monoclonal antibodies. Int.J. Cancer. 46:919.
11. Arch, R., K. Wirth, M. Hofmann, H. Ponta, S. Matzku, P. Herrlich, and M. Zoller. 1992. Participation in normal immune responses of a metastasis inducing splice variant of CD44. Science (Wash. DC). 257:682.
12. Heider, K.H., M. Hofmann, E. Horst, F. van den Berg, H. Ponta, P. Herrlich, and S.T. Pals. 1993. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps .J. Cell Biol. 120:227.
13. Smith, D.B., and K.S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene (Amst.). 67:31.
14. Stamenkovic, I., M. Amiot, J.M. Pesando, and B. Seed. 1989. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell. 56:1057.
15. Angel, P., E.A. Allegretto, S.T. Okuio, K. Hatton, W.J. Boyle, T. Hunter, and M. Karin. 1988. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature (Lond.). 332:166.
16. Kohler, G., and C. Milstein. 1975. Continuous culture of fused cells secreting antibody of predefined specificity. Nature (Lond.). 265:495.
17. Kearney, J.F., A. Radbruch, B. Liesegang, and K. Rajewski. 1979. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J. Immunol. 123:1548.
18. Pals, S.T., F. Hogervorst, G.D. Keizer, T. Thepen, E. Horst, and C.C. Figdor. 1989. Identification of a widely distributed 90-kDa glycoprotein that is homologous to the hermes-1 human lymphocyte homing receptor. J. Immunol. 143:851.
19. Laemmli, U. 1979. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 227:680.
20. The non-Hodgkin’s lymphoma classification project: National Cancer Institute sponsored study of classification of non-Hodgkin’s lymphomas. Summary and description of a working formulation for clinical usage. 1982. Cancer (Phila.). 49:2112.
21. Koopman, G., Y. van Kooyk, M. de Graaff, C.J.L.M. Meyer, C.G. Figdor, and S.T. Pals. 1990. Triggering of the CD44 antigen on T lymphocytes promotes T cell adhesion through the LFA-1 pathway .J. Immunol. 145:3589.
22. Kuyper, K.C., P. Treep-van Leeuwen, F. Miedema, and C.J. Lucas. 1991. Allo-cross-reactivity of a neuraminidase-specific human T-cell clone dependent on presentation of an endogenous B-cell-specific antigen. Eur. J. Immunol. 21:1453.
23. Cohen, P.J., and E. Jaffe. 1990. Histopathology and im-munophenotyping of non-Hogkin’s lymphoma. In The Non-Hodgkin’s Lymphomas. I.T. Magrath, editor. Williams and Wilkins, Baltimore. 49-76.
24. Jalkanen, S., R.F. Bargatze, J. De Los Toyos, and E.C. Butcher. 1986. A lymphocyte cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing. Eur. J. Immunol. 16:1195.
25. Stamenkovic, I., A. Aruffo, M. Amiot, and B. Seed. 1991. The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO (Eur Mol. Biol. Organ.) J. 10:343.
26. Jalkanen, S., M. Jalkanen, R. Bargatze, M. Tammi, and E.C. Butcher. 1988. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J. Immunol. 141:1615.
27. Picker, L.J., M. Nakache, and E.C. Butcher. 1989. Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules in diverse cell types. J. Cell Biol. 109:927.
28. Dougherty, G.J., P.M. Lansdorp, D.L. Cooper, and R.K. Humphries. 1991. Molecular cloning of CD44R1 and CD44R2. Two novel isoforms of the human CD44 lymphocyte homing receptor expressed by hematopoietic cells .J. Exp Med. 174:1.
29. Brown, T.A., T. Bouchard, T. St. John, E. Wayner, and W.G. Carter. 1991. Human kerotinocytes express a new CD44 core protein (CD44E) as a heparansulfate intrinsic membrane proteoglycan with additional exons. J. Cell Biol. 113:207.
30. Shtivelman, E., and M. Bishop. 1991. Expression of CD44 is repressed in neuroblastoma cells. Mol. Cell. Biol. 11:5446.
31. Jackson, D.G., J. Buckley, and J.I. Bell. 1992. Multiple variants of the human lymphocyte homing receptor CD44 generated by insertion at a single site in the extracellular domain. /. Biol. Chem. 267:4732.
32. Aruffo, A., I. Stamenkovic, M. Melnick, C.B. Underhill, and B. Seed. 1990. CD44 is the principle cell surface receptor for hyaluronate. Cell. 61:1303.
33. Carter, W.G., and E.A. Wayner. 1988. Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells .J. Biol. Chem. 263:4193.
34. Jalkanen, S., and M. Jalkanen. 1992. Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J. Cell Biol. 116:817.